why choose us

First received: January 13, 2023

Clinical Trial: A Study to Assess the Adverse Events and How Oral ABBV-552 Capsules Moves Through the Body of Healthy Adult Japanese and Han Chinese Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Volunteers

Study Type: INTERVENTIONAL


Official Title: An Open-label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-552 in Healthy Adult Japanese and Han Chinese Subjects

Brief Summary: This study will assess how safe ABBV-552 is and how ABBV-552 moves through the body of adult healthy Japanese and Han Chinese participants.Adverse Events will be assessed.ABBV-552 is an investigational drug being developed for potential treatment of Alzheimer's disease (AD).Approximately 18 adult healthy Japanese and Han Chinese volunteers will be enrolled in 2 sites in the United States.Japanese participants assigned to Arm 1 will receive ascending doses of ABBV-552 oral capsules once every week for 3…

Read more